Define short-acting insulin. short-acting insulin synonyms, short-acting insulin pronunciation, short-acting insulin translation, English dictionary definition of short-acting insulin. n. 1. A polypeptide hormone that is secreted by the beta cells of the
acting形— 署理形 · 署任形 演技 查看更多用例•查看其他译文 查看其他译文 © Linguee 词典, 2024 使用DeepL翻译器,即刻翻译文本和文档 随打随译 世界领先的质量 拖放文件 立刻翻译 ▾ 外部资源(未审查的) The insulin pump pushes a single type offast-acting insulintocontrolshort-andlongterm glucose...
A case of human insulin allergy in- duced by short-acting and intermediate-acting insulin but not by long- acting insulin. Int J Dermatol 2004;43:597-9.Adachi A, Fukunaga A, Horikawa T. A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by ...
Short-acting insulin Short-acting insulin is the term given to regular human insulin. Its onset occurs within 1 hour and it peaks around 2 to 4 hours, with a duration of action as long as 8 hours. With the delay in onset of action, preprandial regular insulin injected subcutaneously is ...
Our analysis showed that short acting insulin analogues were almost identically effective to regular human insulin in long term glycaemic control and were associated with similar episodes of low blood sugar (hypoglycaemia). No information on late complications such as problems with the eyes, kidneys ...
long-acting beta agonist Long-Acting Beta-Agonist Long-Acting Injection long-acting insulin long-acting insulin long-acting insulin long-acting insulin Long-Acting Muscarinic Antagonists Long-Acting Natriuretic Hormone Long-Acting Oral Nitrates Long-Acting Oral or Ointment ...
Aim: Short-acting insulin analogues, in comparison with regular human insulin (HRI), provide a greater control of postprandial glucose, while their superiority on haemoglobin A1c (HbA1c) is controversial. Method: All randomized controlled trials (RCTs) with a duration >4 weeks comparing short-acti...
The Short-acting Insulin Market is expected to reach USD 7.48 billion in 2025 and grow at a CAGR of 3.46% to reach USD 8.87 billion by 2030. Eli Lilly, Sanofi Aventis, Novo Nordisk AS, Pfizer and Biocon are the major companies operating in this market.
short-acting insulin Short-Acting Neuronal Refractivity Short-Action Magnum Short-and-Long-arm short-arms inspection short-baseline system short-beaked Short-beaked common dolphin Short-beaked common dolphin Short-beaked Echidna Short-billed Short-billed Dowitcher ...
This report describes the efficacy of biosynthetic (BHI) in long-term (one year) therapy of type I diabetic patients previously treated with conventional . The results were compared with those obtained in a group of diabetic patients kept on their usual treatment. In the latter, fasting plasma ...